RADL.Y Stock Overview
Engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
Raia Drogasil S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R$4.50 |
52 Week High | R$14.00 |
52 Week Low | R$3.87 |
Beta | 0.32 |
11 Month Change | -7.41% |
3 Month Change | -13.77% |
1 Year Change | -10.18% |
33 Year Change | 6.89% |
5 Year Change | -18.98% |
Change since IPO | 17.13% |
Recent News & Updates
Recent updates
Shareholder Returns
RADL.Y | US Consumer Retailing | US Market | |
---|---|---|---|
7D | 2.3% | 2.7% | 2.3% |
1Y | -10.2% | 42.9% | 35.1% |
Return vs Industry: RADL.Y underperformed the US Consumer Retailing industry which returned 41.3% over the past year.
Return vs Market: RADL.Y underperformed the US Market which returned 31.5% over the past year.
Price Volatility
RADL.Y volatility | |
---|---|
RADL.Y Average Weekly Movement | 11.7% |
Consumer Retailing Industry Average Movement | 6.3% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: RADL.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RADL.Y's weekly volatility has decreased from 26% to 12% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1905 | 59,341 | Marcílio Pousada | rdsaude.com.br |
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Raia Drogasil S.A. Fundamentals Summary
RADL.Y fundamental statistics | |
---|---|
Market cap | US$7.84b |
Earnings (TTM) | US$194.57m |
Revenue (TTM) | US$6.64b |
39.6x
P/E Ratio1.2x
P/S RatioIs RADL.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RADL.Y income statement (TTM) | |
---|---|
Revenue | R$37.71b |
Cost of Revenue | R$26.45b |
Gross Profit | R$11.26b |
Other Expenses | R$10.15b |
Earnings | R$1.10b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.64 |
Gross Margin | 29.85% |
Net Profit Margin | 2.93% |
Debt/Equity Ratio | 49.1% |
How did RADL.Y perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield17%
Payout RatioDoes RADL.Y pay a reliable dividends?
See RADL.Y dividend history and benchmarksRaia Drogasil dividend dates | |
---|---|
Ex Dividend Date | Jul 12 2024 |
Dividend Pay Date | Dec 16 2024 |
Days until Ex dividend | 119 days |
Days until Dividend pay date | 38 days |
Does RADL.Y pay a reliable dividends?
See RADL.Y dividend history and benchmarks